{"lastName":"Rasschaert","objectUrn":"urn:li:member:306486682","geoRegion":"Brussels Metropolitan Area","fullName":"Gertjan Rasschaert","firstName":"Gertjan","currentPositions":[{"companyName":"UZ Leuven","title":"Medical Doctor, Consultant Gastrointestinal Oncology & Gastroenterology","tenureAtCompany":{"numMonths":8},"companyUrnResolutionResult":{"employeeCountRange":"5001-10000","headquarters":{"country":"Belgium","city":"Leuven","postalCode":"3000","line1":"Herestraat 49"},"website":"http:\/\/www.uzleuven.be","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/uz-leuven\/","industry":"Medical Practices"},"startedOn":{"month":10,"year":2023},"companyUrn":"urn:li:fs_salesCompany:633973"}],"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1697662261218?e=1723075200&v=beta&t=mv4vsBq1gQbPmfIWacM4MMuMLdUHitvMAy7KxlQRBZI","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1697662261218?e=1723075200&v=beta&t=ZTfvPri0IRY57q6qLVEetDYsnrhkWDFw1-zQZVTOevk","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1697662261218?e=1723075200&v=beta&t=-MD4DNJeXK6_BSecO8_itl29-QjDOzNlegw21WfpLGo","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1697662261218?e=1723075200&v=beta&t=bRpwLBiZaXri9d_ZxUf4OzB3eORLGOvfsZaUCsnvAd8","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/D4E03AQElkIUR2RbsRA\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{},"industry":"Hospitals and Health Care","educations":[{"endedOn":{"year":2022},"degree":"Continuing Education","eduId":745682238,"schoolUrn":"urn:li:fs_salesSchool:166698","school":"urn:li:fs_salesSchool:166698","fieldsOfStudy":["Digestive Endosonography"],"schoolName":"UCLouvain - Universit\u00e9 catholique de Louvain","startedOn":{"year":2021}},{"endedOn":{"year":2022},"degree":"Master's degree","eduId":643878666,"schoolUrn":"urn:li:fs_salesSchool:5413","school":"urn:li:fs_salesSchool:5413","fieldsOfStudy":["Master of Medicine in Internal Medicine"],"schoolName":"Vrije Universiteit Brussel","startedOn":{"year":2016}},{"endedOn":{"year":2016},"degree":"Clinical internship","eduId":644921627,"schoolUrn":"urn:li:fs_salesSchool:15250276","school":"urn:li:fs_salesSchool:15250276","fieldsOfStudy":["Master of Medicine in Medicine"],"schoolName":"Tehran University of Medical Sciences","startedOn":{"year":2016}},{"endedOn":{"year":2016},"degree":"Master's degree","eduId":196816295,"schoolUrn":"urn:li:fs_salesSchool:4815","school":"urn:li:fs_salesSchool:4815","fieldsOfStudy":["Master of Medicine in Medicine"],"schoolName":"Universiteit Gent","startedOn":{"year":2012}},{"endedOn":{"year":2015},"degree":"Erasmus clinical internship","eduId":644921606,"schoolUrn":"urn:li:fs_salesSchool:18863041","school":"urn:li:fs_salesSchool:18863041","fieldsOfStudy":["Master of Medicine in Medicine"],"schoolName":"Universit\u00e9 de Lille","startedOn":{"year":2015}},{"endedOn":{"year":2012},"degree":"Bachelor's Degree","eduId":244256060,"schoolUrn":"urn:li:fs_salesSchool:4815","school":"urn:li:fs_salesSchool:4815","fieldsOfStudy":["Bachelor of Science in Medicine"],"schoolName":"Universiteit Gent","startedOn":{"year":2009}},{"endedOn":{"year":2009},"eduId":667948005,"schoolUrn":"urn:li:fs_salesSchool:4815","school":"urn:li:fs_salesSchool:4815","fieldsOfStudy":["Bioengineering and Biomedical Engineering"],"schoolName":"Universiteit Gent","startedOn":{"year":2008}}],"skills":[{"numOfEndorsement":1,"name":"Medicine"},{"numOfEndorsement":0,"name":"Cancer Research"}],"numOfConnections":549,"patents":[],"headline":"MD, Consultant Gastrointestinal Oncology and Gastroenterology Universitair Ziekenhuis Leuven | Colon Cancer research at Tejpar lab KU Leuven | Clinical Trials","courses":[{"name":"Beginselen der elektrocardiografie"},{"name":"Medisch Frans"},{"name":"Inleiding op internationale en globale ontwikkeling en gezondheidszorg"}],"certifications":[],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/gertjan-rasschaert-b8a78486","organizations":[{"name":"Cutting Edge","description":"Music editor, album reviews, concert reviews, expo reviews, interviews (SX, The Horrors, Wild Beasts, Justin Bieber, Efterklang, Twin Shadow, Paul McCartney), opinions","position":"Music editor","startedOn":{"month":8,"year":2009}},{"endedOn":{"month":1,"year":2014},"name":"Subbacultcha! Belgium","position":"Distributor","startedOn":{"month":9,"year":2011}},{"endedOn":{"month":7,"year":2010},"name":"Vlaamse Geneeskundige Kring","position":"Cultuurpraeses 1e bachelor","startedOn":{"month":9,"year":2009}},{"endedOn":{"month":7,"year":2014},"name":"Vlaamse Geneeskundige Kring","position":"Cursus praeses 2e master","startedOn":{"month":9,"year":2013}},{"name":"Vlaamse Vereniging voor Gastro-Enterologie (VVGE)","position":"Member","startedOn":{"month":8,"year":2019}},{"name":"Belgian Society of Gastrointestinal Endoscopy (BSGIE)","position":"Member","startedOn":{"month":8,"year":2019}},{"name":"European Society for Gastrointestinal Endoscopy (ESGE)","position":"Member","startedOn":{"month":1,"year":2020}},{"name":"Belgian Association for the Study of the Liver (BASL)","position":"Member","startedOn":{"month":12,"year":2018}},{"name":"United European Gastroenterology (UEG)","position":"Member","startedOn":{"month":6,"year":2019}},{"name":"Belgian group of young Gastrointestinal Endoscopists (ByGIE)","position":"Board member","startedOn":{"month":3,"year":2020}},{"name":"Belgian Helicobacter and Microbiota Study Group (BHMsG)","position":"Member","startedOn":{"month":9,"year":2020}}],"location":"Brussels Metropolitan Area","publications":[{"publishedOn":{"month":9,"day":12,"year":2014},"description":"Poster presentation\n\nThe most life-threatening aspect of cancer is the local invasive growth and distant\nmetastasis rather than the primary tumoritself. The latter can be considered as an endocrine organ which maintains an intense communication with its environment through delivery of surface proteins and soluble factors (growth factors and cytokines) and release of nanovesicles, called exosomes, for establishment of invasive tumor growth. The specific molecular mechanisms of exosome biogenesis and secretion are still poorly understood. However, an important role in invasive tumor growth is dedicated to the small GTPase Rab27B, a regulator of vesicle exocytosis, that delivers pro-invasive signals for increased invasiveness, tumor size and metastasis of various estrogen receptor (ER)- positive breast cancer cell lines, both in vitro and in vivo...\n","url":"https:\/\/biblio.ugent.be\/publication\/5706294","name":"Screening of inhibitors for modulation of exosome release by cancer cells","publisher":"AMSC","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"}]},{"publishedOn":{"month":3,"year":2020},"description":"Oral presentation Belgian Week of Gastroenterology 2020","url":"https:\/\/bwge2020.sched.com\/event\/YvXc\/continuous-adr50-monitoring-with-individual-feedback-in-lower-gastrointestinal-endoscopy-a-quality-improvement-initiative-in-a-brussels-public-hospital","name":"Continuous ADR50 monitoring with individual feedback in lower gastrointestinal endoscopy, a quality improvement initiative in a Brussels public hospital.","publisher":"Acta Gastro-Enterologica Belgica","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"}]},{"name":"\u201cToothpaste tumour\u201d or severe caseous calcification of the mitral valve annulus: think twice before you brush!","publishedOn":{"month":10,"year":2016},"publisher":"Acta Cardiologica","url":"https:\/\/www.researchgate.net\/publication\/317368026_Toothpaste_tumour_or_severe_caseous_calcification_of_the_mitral_valve_annulus_think_twice_before_you_brushl","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"}]},{"publishedOn":{"month":2,"year":2016},"description":"Merkel cell carcinoma (MCC) is an uncommon, highly aggressive neuroendocrine skin carcinoma that has a tendency for local recurrence and metastatic disease. We report a rare case of recurrent melena in a 77-year-old Caucasian male. Three years earlier, the patient had undergone a radical resection of a para-umbilical MCC. A repeat esophagogastroduodenoscopy proved necessary to identify rapidly proliferating gastric metastasis of MCC as the cause of bleeding.","url":"https:\/\/www.researchgate.net\/publication\/299528961_Rapidly_growing_gastric_metastasis_of_Merkel_cell_carcinoma_an_unusual_cause_of_melena","name":"Rapidly growing gastric metastasis of Merkel cell carcinoma, an unusual cause of melena","publisher":"Acta Clinica Belgica","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAABdp5YYB0vvK87ssJ60LahDM9cM6_BBI5PM,NAME_SEARCH,9-7v)"}]},{"name":"Screening of inhibitors for modulation of exosome release by cancer cells","publishedOn":{"month":5,"year":2014},"description":"Poster presentation Student Research Symposium (SRS) 2015\nUZ Gent","publisher":"STUGG (Studentenraad Geneeskunde en Gezondheidswetenschappen)","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"}]},{"name":"Modulation of exosome release by cancer cells: a screening of potential inhibitors","publishedOn":{"month":3,"year":2015},"description":"Oral presentation","publisher":"9th Leiden international medical student conference. Leiden, The Netherlands: Leiden University Medical Center","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"}]},{"name":"Screening for modulation of exosome release by cancer cells","publishedOn":{"month":9,"year":2015},"description":"Poster presentation","publisher":"Young European Scientists (YES) Meeting, Porto, Portugal","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"}]},{"name":"Automated linkage between endoscopy and histopathology as a holy grail for continuous ADR50 monitoring.","publishedOn":{"month":4,"year":2020},"description":"E-poster presentation at 2020 ESGE Days, Dublin, Ireland","publisher":"Endoscopy","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"}]},{"publishedOn":{"month":3,"year":2020},"description":"Oral presentation Belgian Week of Gastroenterology 2020","url":"https:\/\/bwge2020.sched.com\/event\/YvXK\/opioid-related-sphincter-of-oddi-dysfunction-causing-double-duct-sign-in-a-patient-with-gastric-bypass","name":"Opioid related sphincter of Oddi dysfunction causing double duct sign in a patient with gastric bypass.","publisher":"Acta Gastro-Enterologica Belgica","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"}]},{"publishedOn":{"month":3,"year":2020},"description":"Oral presentation Belgian Week of Gastroenterology 2020","url":"https:\/\/bwge2020.sched.com\/event\/YvYv\/biliary-complications-in-human-alveolar-echinococcosis-a-case-report","name":"Biliary complications in human alveolar echinococcosis: a case report.","publisher":"Acta Gastro-Enterologica Belgica","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"}]},{"name":"Alveolar echinococcosis: One patient presenting the whole panorama of potential biliary complications","publishedOn":{"month":10,"day":11,"year":2020},"description":"Poster presentation at UEG Week 2020","publisher":"UEG (United European Gastroenterology)","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAC--3l0BdGyEF3W1AhPa_aYHOlJKij2PBXM,NAME_SEARCH,X8E9)"}]},{"name":"Primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue with an underlying chronic hepatitis B virus infection: How about aiming at the virus?","publishedOn":{"month":3,"day":5,"year":2021},"description":"Oral presentation at Belgian Week of Gastroenterology","publisher":"Acta Gastro-Enterologica Belgica","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAXBoNABswFofVIFEpgnpY4BIQQttApPcM0,NAME_SEARCH,lNRL)"}]},{"name":"The prevalence of disorders of the gut-brain axis in non-alcoholic fatty liver disease: preliminary results from an observational study","publishedOn":{"month":3,"day":7,"year":2021},"description":"E-poster at Belgian Week of Gastroenterology","publisher":"Acta Gastro-Enterologica Belgica","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAACz14fkBHOKhjn_uSoNrjyc66CFOwgguSMo,NAME_SEARCH,EvAf)"}]},{"publishedOn":{"month":9,"year":2021},"description":"Cover Image","url":"https:\/\/www.thieme-connect.de\/products\/ejournals\/abstract\/10.1055\/a-1487-6187?device=mobile&innerWidth=980&offsetWidth=980","name":"Art in Endoscopy: \u2018The Garden of Earthly Delights\u2019","publisher":"Endoscopy","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"}]},{"name":"Differences in Management of Helicobacter pylori Infection: An Observational Study","publishedOn":{"month":9,"year":2021},"description":"ePoster at European Helicobacter and Microbiota Study Group (EHMSG) Workshop","publisher":"The Year in Helicobacter","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAB4D-Y4B1zgm3vYd4tkG3jq53xq4CMbF9fQ,NAME_SEARCH,kV8C)"}]},{"publishedOn":{"month":10,"day":1,"year":2021},"description":"Cover image","url":"https:\/\/www.thieme-connect.de\/products\/ejournals\/abstract\/10.1055\/a-1487-6211?device=mobile&innerWidth=980&offsetWidth=980","name":"Art in Endoscopy: \u2018Moai Monolyth Mysteries\u2019","publisher":"Endoscopy","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"}]},{"publishedOn":{"month":12,"day":1,"year":2021},"description":"Original research paper","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/34965034\/","name":"The prevalence of disorders of the gut-brain axis in non-alcoholic fatty liver disease: an observational study","publisher":"Acta Gastro-Enterologica Belgica","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAACz14fkBHOKhjn_uSoNrjyc66CFOwgguSMo,NAME_SEARCH,EvAf)"}]},{"name":"Enqu\u00eate sur la prise en charge de l\u2019infection \u00e0 Helicobacter pylori par les practiciens Euro-Africains","publishedOn":{"month":12,"day":4,"year":2021},"description":"Oral presentation JGAF 2021","publisher":"Journal Africain d\u2019H\u00e9pato-Gastroent\u00e9rologie","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"}]},{"publishedOn":{"month":2,"day":11,"year":2022},"description":"Oral presentation at Belgian Week of Gastroenterology","url":"https:\/\/bwge.lineupr.com\/bwge-2022\/item\/bsgi136","name":"Endoscopic submucosal dissection of a solitary gastric plasmocytoma: \u2018third space oddity\u2019","publisher":"Acta Gastro-enterologica Belgica","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"}]},{"publishedOn":{"month":2,"day":10,"year":2022},"description":"Oral presentation at Belgian Week of Gastroenterology","url":"https:\/\/bwge.lineupr.com\/bwge-2022\/item\/bsgi138","name":"Feasibility of implementing the use of regular arrangement of collecting venules in daily endoscopy practice without previous training: early results from a prospective observational study","publisher":"Acta Gastro-Enterologica Belgica","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"}]},{"publishedOn":{"month":2,"day":11,"year":2022},"description":"Oral presentation at Belgian Week of Gastroenterology","url":"https:\/\/bwge.lineupr.com\/bwge-2022\/item\/ybas134","name":"Autoimmune hepatitis developing after SARS-CoV-2 vaccination: series of three cases","publisher":"Acta Gastro-Enterologica Belgica ","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAADS4tSoBlutD-hU9aUIPiQCPHw72fxUKm1o,NAME_SEARCH,JCC9)"}]},{"publishedOn":{"month":2,"day":9,"year":2022},"description":"Oral presentation at Belgian Week of Gastroenterology","url":"https:\/\/bwge.lineupr.com\/bwge-2022\/item\/bhms137","name":"Differences in management of Helicobacter pylori infection: an observational study","publisher":"Acta Gastro-enterologica Belgica","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAB4D-Y4B1zgm3vYd4tkG3jq53xq4CMbF9fQ,NAME_SEARCH,kV8C)"}]},{"name":"A systemic review to predict the outcome of phase III clinical trials in GI oncology","publishedOn":{"month":2,"day":11,"year":2022},"description":"Poster presentation at Belgian Week of Gastroenterology","publisher":"Acta Gastro-Enterologica Belgica","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAABC4BD4BRToYFdaaN02q60vj3TnMICYhUgw,NAME_SEARCH,FKxa)"}]},{"publishedOn":{"month":3,"day":10,"year":2022},"description":"E-video for Endoscopy","url":"https:\/\/www.thieme-connect.com\/products\/ejournals\/abstract\/10.1055\/a-1773-0336","name":"Endoscopic submucosal dissection of a solitary gastric plasmacytoma: \"third space oddity\u00a0\u00bb","publisher":"Endoscopy ","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAABdeG5MB2E-nfRUuQCvmDlf_jFb190o_HUk,NAME_SEARCH,0-5w)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAADM_UvABqUqaaEbWouccPx-SEIHTvLBa9m4,NAME_SEARCH,Pjct)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAk1R9MBI9G6BgHfz2-fD10dakq9Yj0nenk,NAME_SEARCH,HR0B)"}]},{"name":"Feasibility of implementing the use of regular arrangement of collecting venules in daily endoscopy practice without previous training: results from a prospective observational study","publishedOn":{"month":4,"day":28,"year":2022},"description":"E-poster presentation at 2022 ESGE Days, Prague, Czech Republic","publisher":"Endoscopy","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"}]},{"name":"Endoscopic submucosal dissection of a solitary gastric plasmacytoma: \"third space oddity\u00a0\u00bb","publishedOn":{"month":4,"day":28,"year":2022},"description":"E-poster presentation at 2022 ESGE Days, Prague, Czech Republic","publisher":"Endoscopy","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAABdeG5MB2E-nfRUuQCvmDlf_jFb190o_HUk,NAME_SEARCH,0-5w)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAADM_UvABqUqaaEbWouccPx-SEIHTvLBa9m4,NAME_SEARCH,Pjct)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAk1R9MBI9G6BgHfz2-fD10dakq9Yj0nenk,NAME_SEARCH,HR0B)"}]},{"publishedOn":{"month":6,"day":1,"year":2022},"description":"Gertjan Rasschaert, Maria Gomez Galdon, Julien Vandevelde, Pierre Eisendrath\n\nBackground and study aim: Adenoma detection rate in patients aged 50 years or older (ADR50) is considered by the European Society of Gastrointestinal Endoscopy (ESGE) a key performance measures for lower gastrointestinal endoscopy. Technical and human resources constrain implementation of recording quality monitoring. The aim was to deploy an infrastructure for continuous monitoring of endoscopy quality indicators. And to evaluate its potential benefit on quality performance.\nMethods: A company reporting system was adapted by adding a dedicated tab for quality monitoring, including: preparation, progression, number of resected polyps. Automated linkage with the pathology database resulted in continuous monitoring of inter alia: rate of adequate bowel preparation, cecal intubation rate and ADR50. Continuous monitoring was done for all nine endoscopists working at our center, with individual feedback after 4, 9 and 28 months.\nResults: A total of 1434 colonoscopies were performed during the first 9 months of monitoring, 682 during the first 4 months, 752 during the following 5 months. Five months after feedback a global increase in ADR50 of 4.6% (22.9% to 27.5%) (P<0.05) was observed, compared to the first 4 months. Thus meeting the benchmark (\u226525%) recommended by ESGE. A durable effect of monitoring and feedback was observed after 28 months (ADR50: 29.4%).\nConclusions: An easy to use infrastructure for registration of quality monitoring in daily endoscopy practice, automatically linking the pathology database, facilitates continuous monitoring of endoscopy quality indicators. A global and durable ADR50 increase was observed after feedback, considered a quality improvement in performance of lower gastrointestinal endoscopy at our center. (Acta gastroenterol. belg., 2022, 85, 259-266).","url":"https:\/\/www.ageb.be\/Articles\/Volume%2085%20(2022)\/Fasc2\/03-Rasschaert.pdf","name":"Continuous ADR50 monitoring through automated linkage between endoscopy and pathology: a quality improvement initiative in a Brussels public hospital","publisher":"Acta Gastroenterologica Belgica","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAABErqyUBixLXvbx5uh1MAD2EwlaTPKTIcrY,NAME_SEARCH,4exf)"}]},{"publishedOn":{"month":5,"day":31,"year":2022},"description":"S. Kindt, H. Louis, H. De Schepper, J. Arts, P. Caenepeel, D. De Looze, A. Gerkens, T. Holvoet, P. Latour, T. Mahler, F. Mokaddem, S. Nullens, H. Piessevaux, P. Poortmans, G. Rasschaert, M. Surmont, H. Vafa, K. Van Malderen, T. Vanuytsel, F. Wuestenberghs, J. Tack\n\nBackground: Irritable bowel syndrome (IBS) is characterised by recurrent abdominal pain related to defaecation or associated with altered stool frequency or consistency. Despite its prevalence, major uncertainties in the diagnostic and therapeutic management persist in clinical practice.\nMethods: A Delphi consensus was conducted by 20 experts from Belgium, and consisted of literature review and voting process on 78 statements. Grading of recommendations, assessment, development and evaluation criteria were applied to evaluate the quality of evidence.\nResults: Consensus was reached for 50 statements. The Belgian consensus agreed as to the multifactorial aetiology of IBS. According to the consensus abdominal discomfort also represents a cardinal symptom, while bloating and abdominal distension often coexist. IBS needs subtyping based on stool pattern. The importance of a positive diagnosis, relying on history and clinical examination is underlined, while additional testing should remain limited, except when alarm features are present. Explanation of IBS represents a crucial part of patient management. Lifestyle modification, spasmolytics and water-solube fibres are considered first-line agents. The low FODMAP diet, selected probiotics, cognitive behavioural therapy and specific treatments targeting diarrhoea and constipation are considered appropriate. There is a consensus to restrict faecal microbiota transplantation and gluten- free diet, while other treatments are strongly discouraged.\nConclusions: A panel of Belgian gastroenterologists summarised the current evidence on the aetiology, symptoms, diagnosis and treatment of IBS with attention for the specificities of the Belgian healthcare system.","url":"https:\/\/www.ageb.be\/Articles\/Volume%2085%20(2022)\/Fasc2\/14-Kindt.pdf","name":"Belgian consensus on irritable bowel syndrome","publisher":"Acta Gastroenterologica Belgica","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAACz14fkBHOKhjn_uSoNrjyc66CFOwgguSMo,NAME_SEARCH,EvAf)"}]},{"publishedOn":{"month":6,"day":23,"year":2022},"description":"Sa\u00fade-Conde R, Rasschaert G, Bregni G, Hendlisz A, Sclafani F.\n\nPurpose of review \n\nIn this article, we briefly summarise the current knowledge about human epidermal growth factor receptor 2 (HER2) alterations in colorectal cancer (CRC) and provide an overview of the latest published evidence especially regarding standardisation of detection methods\/diagnostic criteria, prognostication, prediction and targeted treatments.\n\nRecent findings \n\nOver the last 18 months, the results of many studies have been presented confirming the therapeutic potential of established anti-HER2 agents either as a monotherapy or in combination, as well as new anti-HER2 agents like antibody-drug-conjugates and tyrosine kinase inhibitors. Also, we have seen confirmation of the utility of liquid biopsy and ctDNA analyses as tool for HER2 detection and patient selection.\n\nSummary \n\nDespite concerning only 5% of metastatic CRC, HER2 represents a valuable target for emerging anti-HER2 therapies that might significantly improve the outcome of these patients. Standardising HER2 detection methods\/diagnostic criteria, and producing high-quality, randomised evidence are the next challenges to meet the standards of regulatory authorities and ultimately have anti-HER2 agents available for use in routine practice.","url":"https:\/\/journals.lww.com\/co-oncology\/Abstract\/9900\/Mind_the_target__human_epidermal_growth_factor.9.aspx","name":"Mind the target: human epidermal growth factor receptor 2 in colorectal cancer.","publisher":"Current Opinion in Oncology","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAABC4BD4BRToYFdaaN02q60vj3TnMICYhUgw,NAME_SEARCH,FKxa)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAADg6nAB7SIxnTmunEA2otEy6WW8SsjUjWg,NAME_SEARCH,8jxW)"}]},{"name":"Cholestasis in a cancer patient: think about the unicorn","publishedOn":{"month":12,"day":1,"year":2022},"publisher":"Acta Gastroenterologica Belgica ","url":"https:\/\/www.ageb.be\/Articles\/Volume%2085%20(2022)\/Fasc4\/21-Rasschaert.pdf","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"}]},{"name":"Feasibility of implementing the use of regular arrangement of collecting venules in daily endoscopy practice without previous training: results from a prospective observational study","publishedOn":{"month":6,"day":1,"year":2022},"description":"Poster presentation @  DDW, San Diego, USA","publisher":"Gastroenterology","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABJEnZoBUkTbQhAzvUOrEXlytnfY_HnK68U,NAME_SEARCH,4Eax)"}]}],"positions":null,"posts":[{"createdAt":1711196820000,"insightId":"d7dc4f1e-9771-4eec-a73f-534c1e97867c","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":11},{"type":"PRAISE","count":3}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7177279744470614016","threadUrn":"urn:li:activity:7177279744470614016","reactionsCount":14,"commentsCount":2,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7177279743979835392","message":{"attributes":[{"start":29,"length":9,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:94210674"}}},{"start":43,"length":4,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:crc"}}},{"start":48,"length":17,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:colorectalcancer"}}},{"start":66,"length":10,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:tejparlab"}}},{"start":77,"length":9,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:633973"}}}],"text":"\ud83e\udd17 Where\u2019s Wally?\u00a0\nThank you OncoDaily\u00a0\ud83c\udf38\n\n#crc\u00a0#colorectalcancer\u00a0#tejparlab\u00a0UZ Leuven\u00a0 "},"rootActivity":{"contentSummaryUnion":{"ingestedContentSummary":{"image":{"attributes":[{"originalImageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4D27AQG8gjm8TM9FLw\/articleshare-shrink_800\/0\/1711356882514?e=1717977600&v=beta&t=L0JHxu8D4xpJ2mFt9mYIhNauXakZ2qNlj7238JeSoyE","sourceType":"URL","imageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4D27AQG8gjm8TM9FLw\/articleshare-shrink_800\/0\/1711356882514?e=1717977600&v=beta&t=L0JHxu8D4xpJ2mFt9mYIhNauXakZ2qNlj7238JeSoyE"}]},"description":"Top 100 Xfluencers in Colorectal Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024 \/ cancer, colorectal cancer, Colorectal Cancer Awareness Month,","resolvedUrl":"https:\/\/oncodaily.com\/41402.html","title":"Top 100 Xfluencers in Colorectal Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024 - OncoDaily"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7177061903519662081","message":{"attributes":[{"start":96,"length":7,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:cancer"}}},{"start":104,"length":17,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:colorectalcancer"}}},{"start":122,"length":10,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:oncodaily"}}},{"start":133,"length":9,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:oncology"}}},{"start":143,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:xfluencers"}}},{"start":155,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:cancercare"}}}],"text":"Top 100 Xfluencers in Colorectal Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024 \n\n#Cancer #ColorectalCancer #OncoDaily #Oncology #Xfluencers #CancerCare "},"entityUrn":"urn:li:share:7177061903519662081"},"entityUrn":"urn:li:share:7177279743979835392"}}},{"createdAt":1710866760000,"insightId":"4022dcd4-3cdc-4e1a-9a95-260926c5c9bb","activityUnion":{"postActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"STILLIMAGE","thumnailUrl":"https:\/\/media.licdn.com\/dms\/image\/D4E22AQG-fVYr6O5h5A\/feedshare-shrink_2048_1536\/0\/1710866761444?e=1720051200&v=beta&t=qRD5HaFsp09uFlzqamYYI_hpF1OmLEQV-8F2oByPg6Q"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":13},{"type":"PRAISE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7175895303391203328","threadUrn":"urn:li:activity:7175895303391203328","reactionsCount":14,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7175895302682357762","message":{"attributes":[{"start":46,"length":12,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:11761935"}}},{"start":445,"length":16,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:machinelearning"}}},{"start":462,"length":3,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:ai"}}},{"start":466,"length":17,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:digitalpathology"}}},{"start":484,"length":4,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:crc"}}},{"start":489,"length":10,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:tejparlab"}}},{"start":501,"length":24,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/eBK6Psfk"}}}],"text":"Our comment on this recent pathomics paper in JAMA Surgery\u00a0by Jian et al. \n\n\ud83e\udd2b Recently, the entrance barrier to machine learning has been substantially lower. Only using it for fancy linear regression is neither lasting nor suitable. \n\n\ud83e\udd14\u00a0One can ask what is the functional meaning of this black box that is called pathomics signature? \n\n\u261d\ufe0f\u00a0We do believe there is an urgent need for balanced golden standard datasets for proper benchmarking. \n\n#machinelearning\u00a0#AI\u00a0#digitalpathology\u00a0#crc\u00a0#tejparlab\n\nhttps:\/\/lnkd.in\/eBK6Psfk"},"entityUrn":"urn:li:share:7175895302682357762"}}},{"createdAt":1710507960000,"insightId":"8436e14c-6b6a-40b3-933e-4d4ee79e4fe2","activityUnion":{"postActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"STILLIMAGE","thumnailUrl":"https:\/\/media.licdn.com\/dms\/image\/D4E22AQHWQZpERy-WkQ\/feedshare-shrink_2048_1536\/0\/1710507966219?e=1720051200&v=beta&t=4oTtJuZYUTA5ys9IccSq1MQz39uKnimLZC2ETk9jykc"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":11},{"type":"PRAISE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7174390407315738625","threadUrn":"urn:li:activity:7174390407315738625","reactionsCount":12,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7174390406644662273","message":{"attributes":[{"start":6,"length":6,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:eortc"}}},{"start":31,"length":10,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:gicancers"}}},{"start":183,"length":66,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:22382"}}},{"start":250,"length":44,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:481100"}}},{"start":295,"length":44,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:22681"}}},{"start":340,"length":9,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:633973"}}},{"start":350,"length":4,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:dio"}}},{"start":355,"length":4,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:crc"}}},{"start":360,"length":8,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:bethere"}}},{"start":369,"length":25,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:1457969"}}},{"start":395,"length":21,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:82955"}}},{"start":417,"length":22,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:97999559"}}}],"text":"Great #EORTC spring meeting on #gicancers in Brussels today. Lots of interesting sessions and expert discussion on (future) trial design. Connecting European GI cancer research. \ud83e\udd1d \n\nEORTC - European Organisation for Research and Treatment of Cancer ESMO - European Society for Medical Oncology\u00a0American Society of Clinical Oncology (ASCO)\u00a0UZ Leuven\u00a0#dio\u00a0#crc\u00a0#bethere\u00a0Kom op tegen Kanker (vzw)\u00a0Institut Jules Bordet Leuven Kankerinstituut"},"entityUrn":"urn:li:share:7174390406644662273"}}},{"createdAt":1710150480000,"insightId":"7fcff62b-23b8-4414-aeb1-e1b4e437bd66","activityUnion":{"postActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"STILLIMAGE","thumnailUrl":"https:\/\/media.licdn.com\/dms\/image\/D4E22AQHPk3aFLy0_iw\/feedshare-shrink_2048_1536\/0\/1710150525107?e=1720051200&v=beta&t=SFW-cbRpuv9K0UtXeoYmTNDUpMlZMwy0mHKFiZoFCOo"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":18},{"type":"INTEREST","count":4}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7172891190948798464","threadUrn":"urn:li:activity:7172891190948798464","reactionsCount":22,"commentsCount":1,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7172891190206402560","message":{"attributes":[{"start":21,"length":18,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:crcawarenessmonth"}}},{"start":190,"length":6,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:crcsm"}}},{"start":197,"length":4,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:crc"}}},{"start":202,"length":53,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:18300345"}}},{"start":256,"length":54,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:1871783"}}},{"start":311,"length":44,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:481100"}}},{"start":356,"length":44,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:22681"}}},{"start":401,"length":9,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:94210674"}}},{"start":411,"length":9,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:67960632"}}},{"start":421,"length":9,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:633973"}}},{"start":431,"length":4,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:dio"}}},{"start":436,"length":24,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:75014703"}}},{"start":461,"length":51,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:1709774"}}},{"start":513,"length":19,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:1457969"}}}],"text":"The exact reason why #crcawarenessmonth matters: something is cooking in the age group of 20-49 years. Also the exact reason why just lowering the screening age to 45 years won't suffice. \n\n#CRCSM #CRC European Society of Gastrointestinal Endoscopy (ESGE) American Society for Gastrointestinal Endoscopy (ASGE) ESMO - European Society for Medical Oncology American Society of Clinical Oncology (ASCO) OncoDaily OncoAlert UZ Leuven #DIO Stop Darmkanker (Belgi\u00eb) Stichting tegen Kanker - Fondation contre le Cancer Kom op tegen Kanker"},"entityUrn":"urn:li:share:7172891190206402560"}}},{"createdAt":1709644080000,"insightId":"7194809b-c7f2-4430-b973-6aa4e97d372a","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":8},{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7170767144459165697","threadUrn":"urn:li:activity:7170767144459165697","reactionsCount":9,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7170767143829917697","message":{"attributes":[],"text":"Proud to be Leuven :)"},"rootActivity":{"contentSummaryUnion":{"ingestedContentSummary":{"image":{"attributes":[{"originalImageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4E27AQHrrFf_7iIkyQ\/articleshare-shrink_800\/0\/1712056972816?e=1717977600&v=beta&t=DA-OYeM61E3hShcElnEXwiqqUMXmjJ6LLpFwv_z95fA","sourceType":"URL","imageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4E27AQHrrFf_7iIkyQ\/articleshare-shrink_800\/0\/1712056972816?e=1717977600&v=beta&t=DA-OYeM61E3hShcElnEXwiqqUMXmjJ6LLpFwv_z95fA"}]},"description":"Het Amerikaanse magazine Newsweek en het dataplatform Statista stelden voor het zesde jaar op rij een lijst op van de beste ziekenhuizen ter wereld: World\u2019s Best Hospitals 2024. UZ Leuven staat daarin als eerste Belgische ziekenhuis op positie 44, en...","resolvedUrl":"https:\/\/bit.ly\/3UZfN5m","title":"UZ Leuven als beste Belgische ziekenhuis in top 20 in Europa volgens Newsweek ranking"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7170712898867052544","message":{"attributes":[{"start":28,"length":8,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:7554"}}},{"start":57,"length":8,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:1042846"}}},{"start":779,"length":22,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/bit.ly\/3UZfN5m"}}},{"start":803,"length":16,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:hospitalranking"}}},{"start":820,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:innovation"}}},{"start":832,"length":9,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:newsweek"}}},{"start":842,"length":5,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:zorg"}}},{"start":848,"length":9,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:research"}}}],"text":"\ud83c\udfe5 Het Amerikaanse magazine Newsweek en het dataplatform Statista stelden voor het zesde jaar op rij een lijst op van de beste ziekenhuizen ter wereld.\u00a0UZ Leuven staat daarin als eerste Belgische ziekenhuis op positie 44, en behaalt een topscore van 93.17% .\u00a0\ud83d\udc4f \n\nProf. dr. Wim Robberecht, gedelegeerd bestuurder van UZ Leuven: \u201cRankings zijn altijd relatief, en bij de gebruikte methodiek van Newsweek zijn belangrijke kanttekeningen te maken. Dat neemt niet weg dat we buitengewoon trots zijn op deze 44ste plaats in de wereldwijde Newsweek ranking. Daarnaast bevestigt de ranking onze positie bij de koplopers in Europa. Dit resultaat is een duidelijke weerspiegeling van de toewijding en excellente zorg van onze medewerkers die dagelijks grenzen verleggen.\"\n\nMeer weten? \ud83d\udc49 https:\/\/bit.ly\/3UZfN5m\n\n#hospitalranking #innovation #newsweek #zorg #research"},"entityUrn":"urn:li:share:7170712898867052544"},"entityUrn":"urn:li:share:7170767143829917697"}}},{"createdAt":1709564880000,"insightId":"80acfb99-46c4-455f-bc06-9a4fd588aa15","activityUnion":{"postActivity":{"contentSummaryUnion":{"ingestedContentSummary":{"image":{"attributes":[{"originalImageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4D27AQFHz4gOQYJQWw\/articleshare-shrink_800\/0\/1714417975539?e=1717977600&v=beta&t=5STqmsKsFH3-IAg1C7QpGAGloUCGPEjgo1upbM8YV54","sourceType":"URL","imageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4D27AQFHz4gOQYJQWw\/articleshare-shrink_800\/0\/1714417975539?e=1717977600&v=beta&t=5STqmsKsFH3-IAg1C7QpGAGloUCGPEjgo1upbM8YV54"}]},"description":"Gastrointestinal cancers account for a quarter of the global cancer incidence and a third of cancer-related deaths. We sought to estimate the lifetime risks of developing and dying from gastrointestinal cancers at the country, world region, and global levels in 2020. For this population-based systematic analysis, we obtained estimates of gastrointestinal cancer incidence and mortality rates from GLOBOCAN for 185 countries, alongside all-cause mortality and population data from the UN. Countries were categorised into quartiles of the Human Development Index (HDI). The lifetime risk of gastrointestinal cancers was estimated with a standard method that adjusts for multiple primaries, taking into account competing risks of death from causes other than cancer and life expectancy. The global lifetime risks of developing and dying from gastrointestinal cancers from birth to death was 8\u00b720% (95% CI 8\u00b718\u20138\u00b721) and 6\u00b717% (6\u00b716\u20136\u00b718) in 2020. For men, the risk of developing gastrointestinal cancers was 9\u00b753% (95% CI 9\u00b751\u20139\u00b755) and of dying from them 7\u00b723% (7\u00b722\u20137\u00b725); for women, the risk of developing gastrointestinal cancers was 6\u00b784% (6\u00b782\u20136\u00b785) and of dying from them 5\u00b709% (5\u00b708\u20135\u00b710). Colorectal cancer presented the highest risk, accounting for 38\u00b75% of the total lifetime risk of developing, and 28\u00b72% of dying from, gastrointestinal cancers, followed by cancers of the stomach, liver, oesophagus, pancreas, and gallbladder. Eastern Asia has the highest lifetime risks for cancers of the stomach, liver, oesophagus, and gallbladder, Australia and New Zealand for colorectal cancer, and Western Europe for pancreatic cancer. The lifetime risk of gastrointestinal cancers increased consistently with increasing level of HDI; however, high HDI countries (the third HDI quartile) had the highest death risk. The global lifetime risk of gastrointestinal cancers translates to one in 12 people developing, and one in 16 people dying from, gastrointestinal cancers. The identified high risk and observed disparities across countries warrants context-specific targeted gastrointestinal cancer control and health systems planning. Beijing Nova Program, CAMS Innovation Fund for Medical Sciences, and Talent Incentive Program of Cancer Hospital, CAMS (Hope Star).","resolvedUrl":"https:\/\/www.thelancet.com\/journals\/langas\/article\/PIIS2468-1253(23)00366-7\/fulltext","title":"Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":10},{"type":"INTEREST","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7170434823885451268","threadUrn":"urn:li:activity:7170434823885451268","reactionsCount":11,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7170434821444362240","message":{"attributes":[{"start":111,"length":18,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:crcawarenessmonth"}}},{"start":130,"length":4,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:crc"}}},{"start":135,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:gioncology"}}},{"start":157,"length":10,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:tejparlab"}}},{"start":223,"length":24,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/gs3jgSTe"}}}],"text":" The global lifetime risk of GI cancer is 1 out of 12 people. While 1 in 16 people are dying from GI cancer. \n\n#crcawarenessmonth #crc #gioncology @UZLeuven #tejparlab @komop_tgkanker @Stkstichting @TheLancet @GLOBOCAN_GCO\nhttps:\/\/lnkd.in\/gs3jgSTe"},"entityUrn":"urn:li:share:7170434821444362240"}}},{"createdAt":1714064520000,"insightId":"32a0ebce-e18e-4fcf-a2fc-eb2b8c20af95","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7189253971474067457,7189307838458998785)","threadUrn":"urn:li:ugcPost:7189253971474067457","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Congratulations, Miranda! \ud83d\ude09"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7189253971474067457"}}}]}